Efficacy and Safety of Biosimilar Cetuximab Versus Innovator Cetuximab in Indian Patients With Head and Neck Cancer: A Multicenter, Randomized, Double-Blind, Phase III Trial by Kumar Prabhash, Chetan Deshmukh, Hemant Malhotra, Atul Sharma, Minish Jain, Nilesh Dhamne, Rajnish Nagarakar, Prasantha Ganesan, Vijay K. Mahobia, Chandan K. Das, Rejnish Kumar, Prakash S. Shivanna, Manu P. Avaronnan, Puligundla K. Chaithanya, Vaibhav Chaudhary, Kartar Singh, Suhas Aagre, Bellala Ravishankar, Dhruv Mehta, Kandipalli Shilpa, Vashishth Maniar, Koushik Chatterjee, Saroj D. Majumdar, Rohitashwa Dana, Vanita Noronha, Nandini Menon, Akhilesh Sharma, Roshan Pawar, Vinayaka Shahavi, Rajiv Yadav, Amol Aiwale

Get full text